A major shift in stroke care is underway as tenecteplase outperforms alteplase. This new treatment could redefine recovery ...

For patients with large vessel occlusion presenting between 4.5 and 24 hours, intra-arterial tenecteplase after successful ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days ...

Early findings suggest that IA tenecteplase after successful thrombectomy is safe and improves functional outcomes over standard care in anterior circulation LVO stroke.

Roche said it has removed its thrombolytic drug tenecteplase from phase 3 for for acute ischaemic stroke, along with several earlier-stage projects. The fibrin-specific plasminogen activator ...

The results increase “my confidence that this approach has merit,” Lauren Sansing says. More trials are on the way.

The standard treatment for these strokes involves removing the clot using a thin tube (catheter) or a stent, a procedure ...

Four patients with severe heart attacks have been saved under the STEMI project at Tarn Taran Civil Hospital in the past two ...

Injecting tenecteplase into the artery after clot removal helps improve recovery in stroke survivors, leading to better functional outcomes.

For patients with large vessel occlusion presenting between 4.5 and 24 hours, intra-arterial tenecteplase after successful ...